# Cognitive Detection of Preclinical AD: Validation Using Biomarkers

> **NCT02616679** · — · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 81 (actual)

## Conditions studied

- Mild Cognitive Impairment

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02616679
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-05
- **Primary completion:** 2020-08-12
- **Final completion:** 2020-08-12
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2021-01-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02616679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02616679, "Cognitive Detection of Preclinical AD: Validation Using Biomarkers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02616679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*